Polymorph of HDAC6-selective inhibitor and application thereof
US11345682B2 · kind B2 · utility
0Cited by
3References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 3, 2019 |
| Grant date | May 31, 2022 |
| Priority date | — |
| Expiry date | Jul 3, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed in the present invention are a polymorph A of a compound represented by formula (I), and an application thereof in preparation of drugs for treating HDAC6-associated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.